SCOPUS 정보 검색 플랫폼

Journal of Association of Physicians of India

Volumn 56, Issue JUNE, 2008, Pages 409-410

XDR-TB in India: When will we heed the alarm?

(1) Udwadia, Z F a

a P D HINDUJA NATIONAL HOSPITAL (India)

Author keywords

[No Author keywords available]

Indexed keywords

TUBERCULOSTATIC AGENT;

CLINICAL TRIAL; DRUG DESIGN; EDITORIAL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INDIA; INFECTION CONTROL; MICROBIOLOGY; MULTIDRUG RESISTANCE; TREATMENT FAILURE; TUBERCULOSIS;

ANTITUBERCULAR AGENTS; CLINICAL TRIALS AS TOPIC; COMMUNICABLE DISEASE CONTROL; DRUG DESIGN; DRUG RESISTANCE, MULTIPLE, BACTERIAL; EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS; HIV INFECTIONS; HUMANS; INDIA; TREATMENT FAILURE;

EID: 44649155728 PISSN: 00045772 EISSN: None Source Type: Journal
DOI: None Document Type: Editorial

Times cited : (9)

References (10)

1
- 33645119729
- Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004
- CDC
- CDC. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs worldwide, 2000-2004. MMWR Morb Mortal Wkly Rep 2006;55:301-5.
- (2006) MMWR Morb Mortal Wkly Rep , vol.55 , pp. 301-305

2
- 84878708677
- Anti tuberculosis drug resistance in the world
- th global report. WHO/HTM/TB/2008.394.
- th global report. WHO/HTM/TB/2008.394

3
- 44649166226
- High prevalence of XDR-TB from a tertiary care hospital in India
- San Francisco, USA; May, Abstract A510
- Jain S, Rodrigues C, Mehta A, Udwadia ZF. High prevalence of XDR-TB from a tertiary care hospital in India. American Thoracic Society 2007 International Conference, San Francisco, USA; May 2007. Abstract A510.
- (2007) American Thoracic Society 2007 International Conference
- Jain, S.¹ Rodrigues, C.² Mehta, A.³ Udwadia, Z.F.⁴

4
- 34250721584
- XDR tuberculosis in India: What's in a name?
- Udwadia ZF, Jain S, Rodrigues C, Mehta A. XDR tuberculosis in India: what's in a name? Lancet ID 2007;7:441-2.
- (2007) Lancet ID , vol.7 , pp. 441-442
- Udwadia, Z.F.¹ Jain, S.² Rodrigues, C.³ Mehta, A.⁴

5
- 33750629139
- Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa
- Gandhi NR, Moll A, Sturm AW, et al. Extensively drug resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 2006;368: 1575-80.
- (2006) Lancet , vol.368 , pp. 1575-1580
- Gandhi, N.R.¹ Moll, A.² Sturm, A.W.³

6
- 40749118083
- Migliori GB, Lange C, Giradi E, Centis R et al. Clinical Infectious Disease 2008;46:958-9.
- (2008) Clinical Infectious Disease , vol.46 , pp. 958-959
- Migliori, G.B.¹ Lange, C.² Giradi, E.³ Centis, R.⁴

7
- 44649141765
- ORG Nationwide Audit, Nov
- ORG Nationwide Audit. MAT Nov 2004.
- (2004) MAT

8
- 44649191014
- The rapid development of fluoroquinolone resistance in M. tuberculosis
- Ginsburg AS, Woolwine SC, Hooper N et al. The rapid development of fluoroquinolone resistance in M. tuberculosis. N Eng J Med 2003;24:134-6.
- (2003) N Eng J Med , vol.24 , pp. 134-136
- Ginsburg, A.S.¹ Woolwine, S.C.² Hooper, N.³

9
- 33749627319
- Rapid detection of tuberculosis and drug resistant tuberculosis
- Iseman MD, Heifets LBN. Rapid detection of tuberculosis and drug resistant tuberculosis New Eng J Med 2006;355:1606-8.
- (2006) New Eng J Med , vol.355 , pp. 1606-1608
- Iseman, M.D.¹ Heifets, L.B.N.²

10
- 34547619993
- New tuberculous therapeutics; a growing pipeline
- Spigelman MK. New tuberculous therapeutics; a growing pipeline. J Infect Dis 2007;196:S86-107.
- (2007) J Infect Dis , vol.196
- Spigelman, M.K.¹

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.